Table 4.
Mutation (Legacy Name) |
Mutation (HGVS) | Sanger | AmpliSeq CFTR Community Panel |
Accel- Amplicon CFTR Panel |
CF 139- Variant Assay |
InPlex CF 40+4 |
xTAG CF39v2 kit |
xTAG CF60v2 kit |
TaqMan SNP Genotyping |
---|---|---|---|---|---|---|---|---|---|
F508del | c.1521_1523delCTT | + | + | + | + | + | + | + | + |
I507del | c.1519_1521delATC | + | + | + | + | + | + | + | + |
G542X | c.1624G>T | + | + | + | + | + | + | + | + |
G85E | c.254G>A | + | + | + | + | + | + | + | + |
R117H | c.350G>A | + | + | + | + | + | + | + | + |
621 + 1G>T | c.489+ 1G>T | + | + | + | + | + | + | + | + |
711 + 1G->T | c.579+ 1G>T | + | + | + | + | + | + | + | + |
R334W | c.1000C>T | + | + | + | + | + | + | + | + |
R347P | c.1040G>C | + | + | + | + | + | + | + | + |
A455E | c.1364C>A | + | + | + | + | + | + | + | + |
1717–1G>A | c.1585+ 1G>A | + | + | + | + | + | + | + | + |
R560T | c.1679G>C | + | + | + | + | + | + | + | + |
R553X | c.1657C>T | + | + | + | + | + | + | + | + |
G551D | c.1652G>A | + | + | + | + | + | + | + | + |
1898+ 1G>A | c.1766+ 1G>A | + | + | + | + | + | + | + | + |
2184delA | c.2052delA | + | +* | + | + | + | + | + | + |
2789+5G>A | c.2657 + 5G>A | + | + | + | + | + | + | + | + |
3120+ 1G>A | c.2988+ 1G>A | + | + | + | + | + | + | + | + |
R1162X | c.3484C>T | + | + | + | + | + | + | + | + |
3659delC | c.3528delC | + | + | + | + | + | + | + | + |
3849+ 10kbC>T | c.3717+ 12191C>T | + | + | + | + | + | + | + | + |
W1282X | c.3846G>A | + | + | + | + | + | + | + | + |
N1303K | c.3909C>G | + | + | + | + | + | + | + | + |
F508C | c.1523T>G | + | + | + | nr | + | nr | nr | + |
T5 | c.1210–12[5] | + | + | + | CR | + | CR | CR | + |
T7 | c.1210–12[7] | + | ND | + | CR | + | CR | CR | + |
T9 | c.1210–12[9] | + | ND | + | CR | + | CR | CR | + |
Abbreviations: ACMG, American College of Medical Genetics; CF, cystic fibrosis; CFTR, CF transmembrane regulator; CR, conditionally reported with an R117H present; ND, not distinguishable; nr, not reported but used for correct mutation interpretation; SNP, single-nucleotide polymorphism;
+, mutations detected;
+*, not assayed in this study but detectable by method.
Boldface entries indicates ACMG mutations.